Grazia Arpino

Summary

Affiliation: Federico II University
Country: Italy

Publications

  1. doi request reprint Molecular mechanism and clinical implications of endocrine therapy resistance in breast cancer
    Grazia Arpino
    Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Universita di Napoli Federico II, Napoli, Italy
    Oncology 77:23-37. 2009
  2. doi request reprint Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study
    Grazia Arpino
    Department of Clinical Medicine and Surgery, University of Naples Federico II, Via S Pansini 5, 80131, Naples, Italy
    J Cancer Res Clin Oncol 142:669-78. 2016
  3. doi request reprint Features of aggressive breast cancer
    Grazia Arpino
    Universita di Napoli Federico II, Napoli, Italy Electronic address
    Breast 24:594-600. 2015
  4. doi request reprint Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy
    Grazia Arpino
    Department of Clinical Medicine and Surgery, Oncology Division, University of Naples Federico II Medical School, Via S Pansini 5, 80131, Naples, Italy
    Breast Cancer Res Treat 154:127-32. 2015
  5. doi request reprint Gene expression profiling in breast cancer: a clinical perspective
    Grazia Arpino
    Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Universita di Napoli Federico II, Napoli, Italy
    Breast 22:109-20. 2013
  6. pmc Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study
    Grazia Arpino
    Department of Clinical Medicine, Division of Medical Oncology, University of Naples Federico II, Naples, Italy
    Anticancer Drugs 26:117-22. 2015
  7. ncbi request reprint A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer
    Michele De Laurentiis
    Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Universita Federico II, Napoli, Italy
    Clin Cancer Res 11:4741-8. 2005

Detail Information

Publications7

  1. doi request reprint Molecular mechanism and clinical implications of endocrine therapy resistance in breast cancer
    Grazia Arpino
    Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Universita di Napoli Federico II, Napoli, Italy
    Oncology 77:23-37. 2009
    ....
  2. doi request reprint Demographic, tumor and clinical features of clinical trials versus clinical practice patients with HER2-positive early breast cancer: results of a prospective study
    Grazia Arpino
    Department of Clinical Medicine and Surgery, University of Naples Federico II, Via S Pansini 5, 80131, Naples, Italy
    J Cancer Res Clin Oncol 142:669-78. 2016
    ..However, RCT patients may not invariably be representative of patients routinely seen in clinical practice (CP). To address this issue, we compared the clinical and tumor features of RCT and CP patients with HER2-positive BC...
  3. doi request reprint Features of aggressive breast cancer
    Grazia Arpino
    Universita di Napoli Federico II, Napoli, Italy Electronic address
    Breast 24:594-600. 2015
    ..Breast cancer is a heterogeneous disease, both clinically and biologically, which may be responsible for the wide range of survival durations for patients with metastatic disease...
  4. doi request reprint Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy
    Grazia Arpino
    Department of Clinical Medicine and Surgery, Oncology Division, University of Naples Federico II Medical School, Via S Pansini 5, 80131, Naples, Italy
    Breast Cancer Res Treat 154:127-32. 2015
    ..These changes occurred during the first 2 years after diagnosis and were not specifically related to chemotherapy, menopausal status, or initial body weight. ..
  5. doi request reprint Gene expression profiling in breast cancer: a clinical perspective
    Grazia Arpino
    Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Universita di Napoli Federico II, Napoli, Italy
    Breast 22:109-20. 2013
    ....
  6. pmc Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study
    Grazia Arpino
    Department of Clinical Medicine, Division of Medical Oncology, University of Naples Federico II, Naples, Italy
    Anticancer Drugs 26:117-22. 2015
    ....
  7. ncbi request reprint A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer
    Michele De Laurentiis
    Dipartimento di Endocrinologia ed Oncologia Molecolare e Clinica, Universita Federico II, Napoli, Italy
    Clin Cancer Res 11:4741-8. 2005
    ..Clinical data, however, have been conflicting. We have conducted a meta-analysis on the interaction between the response to endocrine treatment and the overexpression of HER-2 in metastatic breast cancer...